Genetic Analysis of Neurodegeneration in Drosophila
Genetic Analysis of Neurodegeneration in Drosophila
批准号:
9223746
负责人:
DAVID WASSARMAN
金额:
$32.92万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2019-03-31
关键词:
ATM geneAgeAlzheimer&aposs DiseaseAnimal ModelAtaxia TelangiectasiaCause of DeathCell CycleCell Cycle RegulationCell NucleusCleaved cellCognitive deficitsDataDiseaseDrosophila genusDrosophila melanogasterEventExcisionExperimental ModelsGene TargetingGenesGenetic TranscriptionGoalsHealthHumanImmuneIndividualInnate Immune ResponseMammalsMediatingMitotic Cell CycleModelingMolecularMolecular GeneticsMutateMutationNF-kappa BNerve DegenerationNeurodegenerative DisordersNeurogliaNeuronsPathway interactionsPhosphorylationProteinsPublishingRare DiseasesResearchRoleSignal TransductionStimulusTNF geneantimicrobial peptideflygain of functiongenetic analysishuman diseaseloss of functionmutantneuron lossnovelpathogenpreventprotein functionpublic health relevancetargeted treatmenttooltranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Neurodegeneration is characterized by the progressive loss of neuron function resulting in physical and cognitive defects that can cause death. Neurodegenerative diseases such as Alzheimer's are a substantial health issue. Currently, there is no effective means to prevent neurodegeneration in any disease. We want to understand the molecular and cellular events that are required for neurodegeneration in a rare disease Ataxia-telangiectasia (A-T), which is caused by mutation of the A- T mutated (ATM) gene. In A-T, neurodegeneration begins before the age of two and worsens with age. We have used Drosophila melanogaster as an experimental model to study A-T. To date, we have found that ATM mutations in neurons disrupt cell cycle regulation, which causes quiescent neurons to reenter the mitotic cell cycle and die. We have also found that ATM mutations in glial cells activate the innate immune response through the NF-�B transcription factor Relish, which causes neurons to die. These findings in flies are relevant to humans. Neuron cell cycle reentry and activation of the innate immune response occur in individuals with A-T as well as in individuals with other neurodegenerative diseases such as Alzheimer's. In the proposed studies, we will continue to use flies because they are the only animal model currently available that undergoes neurodegeneration as a result of ATM mutation. Moreover, the arsenal of molecular and genetic tools available in flies make it possible to rapidly investigate the molecules and pathways that underlie neurodegeneration, providing a framework for developing targeted therapies. To delineate the pathway of events that cause neurodegeneration in A-T we proposed to: (1) determine the factors and signaling events that activate Relish to cause neurodegeneration in ATM mutant flies and (2) determine the transcription targets of Relish at are necessary and sufficient to cause neurodegeneration in ATM mutant flies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anesthetic-Induced Neurotoxicity: Molecular Pathways and Genetic Risk Factors
-
批准号:10549751
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2020
-
负责人:DAVID WASSARMAN
-
依托单位:
A Fly Model of Traumatic Brain Injury
-
批准号:9034777
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2016
-
负责人:DAVID WASSARMAN
-
依托单位:
Genetic Analysis of Neurodegeneration in Drosophila
-
批准号:9018070
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2014
-
负责人:DAVID WASSARMAN
-
依托单位:
Genetic Analysis of Neurodegeneration in Drosophila
-
批准号:8688528
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2014
-
负责人:DAVID WASSARMAN
-
依托单位:
Genetic Analysis of Neurodegeneration in Drosophila
-
批准号:8814288
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2014
-
负责人:DAVID WASSARMAN
-
依托单位:
Neuroprotective drugs for A-T
-
批准号:8616449
-
项目类别:
-
资助金额:$22.17万
-
财政年份:2013
-
负责人:DAVID WASSARMAN
-
依托单位:
Neuroprotective drugs for A-T
-
批准号:8739687
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2013
-
负责人:DAVID WASSARMAN
-
依托单位:
Genetic Analysis of Ataxia-telangiectasia
-
批准号:7537212
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2007
-
负责人:DAVID WASSARMAN
-
依托单位:
Genetic Analysis of Ataxia-telangiectasia
-
批准号:7913120
-
项目类别:
-
资助金额:$2.78万
-
财政年份:2007
-
负责人:DAVID WASSARMAN
-
依托单位:
Genetic Analysis of Ataxia-telangiectasia
-
批准号:7738931
-
项目类别:
-
资助金额:$30.86万
-
财政年份:2007
-
负责人:DAVID WASSARMAN
-
依托单位:
Genetic Analysis of Ataxia-telangiectasia
-
批准号:7373017
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2007
-
负责人:DAVID WASSARMAN
-
依托单位:
Genetic Analysis of Ataxia-telangiectasia
-
批准号:8197347
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2007
-
负责人:DAVID WASSARMAN
-
依托单位:
Genetic Analysis of Ataxia-telangiectasia
-
批准号:7989397
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2007
-
负责人:DAVID WASSARMAN
-
依托单位:
Mechanism of Transcription Control by Drosophila TAF250
-
批准号:6530212
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2002
-
负责人:DAVID WASSARMAN
-
依托单位:
Mechanism of Transcription Control by Drosophila TAF250
-
批准号:6747344
-
项目类别:
-
资助金额:$28.5万
-
财政年份:2002
-
负责人:DAVID WASSARMAN
-
依托单位:
Mechanism of Transcription Control by Drosophila TAF250
-
批准号:6909982
-
项目类别:
-
资助金额:$28.49万
-
财政年份:2002
-
负责人:DAVID WASSARMAN
-
依托单位:
Mechanism of Transcription Control by Drosophila TAF250
-
批准号:7092977
-
项目类别:
-
资助金额:$27.8万
-
财政年份:2002
-
负责人:DAVID WASSARMAN
-
依托单位:
Mechanism of Transcription Control by Drosophila TAF250
-
批准号:6603455
-
项目类别:
-
资助金额:$28.52万
-
财政年份:2002
-
负责人:DAVID WASSARMAN
-
依托单位:
RNA POLYMERASE 11 TRANSCRIPTIONAL REGULATION IN DROSOPHILA
-
批准号:2452881
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DAVID WASSARMAN
-
依托单位:
GENETIC ANALYSIS OF RNA POLYMERASE II TRANSCRIPTIONAL REGULATION IN DROSOPHILA
-
批准号:6108083
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:DAVID WASSARMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: